key: cord-0684073-dpnm8r5f authors: Osuna‐Padilla, Iván Armando; Rodríguez‐Moguel, Nadia Carolina; Rodríguez‐Llamazares, Sebastián; Aguilar‐Vargas, Adriana; Casas‐Aparicio, Gustavo Alejandro; Ríos‐Ayala, Martin Armando; Hernández‐Cardenas, Carmen Margarita title: Low phase angle is associated with 60‐day mortality in critically ill patients with COVID‐19 date: 2021-08-31 journal: JPEN J Parenter Enteral Nutr DOI: 10.1002/jpen.2236 sha: 7935ceceb20b0142c9da8eff373d55b38e6563bd doc_id: 684073 cord_uid: dpnm8r5f BACKGROUND: Malnutrition status, body composition indicators, and bioelectrical impedance analysis (BIA) parameters have been associated with increased risk of death in several pathologies. The aim of this study was to describe the associations between phase angle (PhA) indicators obtained by BIA with length of hospital stay, days on mechanical ventilation, and 60‐day mortality in critically ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). METHODS: This is a prospective cohort of mechanically ventilated patients with coronavirus disease 2019 (COVID‐19). We assessed nutrition risk and body composition with BIA within 48 h from intensive care unit admission. Logistic and linear regression models were used to analyze the association between variables and clinical outcomes. Survival analysis by PhA value was performed using Kaplan‐Meier curves. RESULTS: Sixty‐seven patients were included. PhA (odds ratio [OR], 0.36; P = .002), standardized PhA (SPA) (OR, 0.45; P = .001), and extracellular water/total body water ratio (OR, 3.25; P = .002) were significant predictors of 60‐day mortality. PhA <3.85° in females and <5.25° in males showed good and fair discrimination, respectively, for mortality prediction. Using cutoff values, low PhA was associated with a significantly increased risk of 60‐day mortality (hazard ratio, 3.08; 95% CI, 1.12–8.41; P = .02). No association was detected for SPA. CONCLUSION: Low PhA values could be a predictor of 60‐day mortality in critically ill patients with COVID‐19. This biological marker could be incorporated as part of nutrition and mortality risk assessment in this population. Until August 2021, >209 million cases and 4.4 million deaths caused by coronavirus disease 2019 (COVID-19) have been reported worldwide. 1 Because severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection primarily affects the respiratory system, severe illness often presents as pneumonia and acute respiratory distress syndrome requiring mechanical ventilation (MV) along with admission to intensive care units (ICUs). 2 Nutrition risk has been associated with higher mortality and longer length of stay (LOS) in the hospital in COVID-19 and non-COVID-19 patients. [3] [4] [5] Nutrition risk screening and anthropometric assessment should be performed in the first 24-48 h of ICU admission in order to identify malnourished patients who will benefit from early nutrition support. 6, 7 Anthropometric assessments of nutrition status, including body weight and height estimation for body mass index (BMI) calculation, often lack accuracy because of fluid overload that might be present after intravenous fluid resuscitation. 8 Bioelectrical impedance analysis (BIA) might be useful in critically ill patients but is not an accurate tool to measure body composition in overhydrated patients or during intravenous infusion therapy. [9] [10] [11] Some components of BIA such as phase angle (PhA), an indicator of cell membrane integrity, as well as standardized PhA (SPA) have shown to effectively predict poor prognosis at an early stage in several pathologies (liver diseases, chronic kidney disease, human immunodeficiency virus). [12] [13] [14] [15] It is obtained from the arctangent of the ratio of resistance (opposition to an electric current) and reactance (capacitance of tissues) measured by bioimpedance (BIA). 12 PhA reference values should be established according to sex, age, population, and health condition. 16, 17 In noncritically ill patients with COVID-19, a low PhA value was associated with disease severity and increased mortality risk; 18 This was a prospective observational study in a cohort of mechanically ventilated patients. Patients who were admitted to the ICU from September 15, 2020, to January 30, 2021, at the National Institute of Respiratory Diseases in Mexico City, Mexico, were enrolled. Adults (age ≥ 18 years) diagnosed with COVID-19 (confirmed by both reverse transcriptation -polymarase chain reaction (RT-PCR)) for SARS-CoV-2 and suggestive tomographic findings were included. All patients with BIA assessment during the first 48 h of initiating MV were included. This study was reviewed and approved by the institutional review board (#C16-21). The nutrition risk of each patient was calculated using the modified Nutrition Risk in the Critically Ill (NUTRIC) score, which includes age, Sequential Organ Failure Assessment (SOFA) score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score at admission, number of comorbidities, and pre-ICU hospital LOS during the first 24 h of initiating MV. High nutrition risk was established with a score ≥5. 6 Anthropometric assessment included mid-arm circumference, calf circumference, abdominal circumference, and half-arm span; measurements were recorded using a tape graduated in centimeters with 0.1cm precision (seca 201). Anthropometry was assessed using the standard procedures described by Lohman et al. 20 Mid-arm circumference was measured at the midpoint between the tip of acromion process and tip of the olecranon process. Calf circumference was measured by wrapping the tape around the widest part of the calf. Abdominal circumference is measured at the midpoint of the line between the rib or costal margin and the iliac crest. Body weight and height were estimated using validated equations. 21 BMI was calculated accordingly. Days on invasive MV, LOS in days, and 60-day all-cause mortality were recorded. Sample size calculation was based on the difference in PhA between survivors (5.0 • ± 1.3 • ) and nonsurvivors (4.1 • ± 1.2 • ) as reported by Stapel et al. 25 Based on this information, a power of 80%, and a level of significance of 5%, the required sample size was 64 patients. Data were analyzed using Stata Intercooled (version 14, StataCorp) and GraphPad Prism (GraphPad Software, Inc). Normality of the distribution of quantitative variables was verified by the Shapiro-Wilk test. Descriptive statistics were used for the analysis of categorical variables (absolute and relative frequency) and quantitative variables (mean and SD or median and interquartile range). Clinical data and BIA values between survivors and nonsurvivors were compared using the Student t-test, Mann-Whitney U test, or the chi-squared test. A logistic regression model was used to analyze the association of variables and 60-day mortality. Pearson and Spearman tests were used to analyze the correlation between PhA and SPA with severity scores. The PhA cutoff value for predicting mortality was analyzed using the receiver operating characteristic (ROC) curve, obtaining sensitivity and specificity. The area under the curve (AUC) was used as an overall measure of discriminative capacity accuracy interpreted as follows: no discrimination, AUC ≤ 0.5; fail discrimination, 0.5-0.6; poor discrimination, 0.6-0.7; fair discrimination, 0.7-0.8; good discrimination, 0.8-0.9; and excellent discrimination, ≥0.9. 26 We also performed the Kaplan-Meier survival analysis at 60 days with log-rank test and the Cox proportional hazards model by PhA values adjusted for NUTRIC score and age for PhA cutoff models and adjusted only for NUTRIC score for SPA (considering that PhA values were adjusted by the mean for age). NUTRIC score was selected because of the inclusion of both severity scales (APACHE II and SOFA). Variables were selected according to suspected risk factors for the outcome of interest. Statistical significance was defined as P < .05. In total, 67 patients (76% males), who had a mean age of 55.3 ± 13.6 years, were enrolled in this study. Patients' characteristics are shown in Table 1 . Mean SOFA score was 9 ± 2, and APACHE II was 21 ± 5. Overweight or obesity was identified in 85% of patients by BMI. Overweight or obesity was detected in all female patients (n = 16). The median number of ventilation days was 13 (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) , and the median LOS was 20 days (15-28 days). The 60-day mortality rate was 37.3%. The clinical characteristics of the 60-day survivors and nonsurvivors are shown in Table 2 13). Figure 1 shows the 60-day mortality as Kaplan-Meier curves for the low vs normal PhA groups. In-hospital mortality OR (95% CI) a P-value In this study, low PhA determined by BIA in critically ill patients with COVID-19 was associated with 60-day mortality, but not with LOS and MV days. PhA is an indicator that is directly obtained from BIA and not subjected to mathematical models or interference from hydration. It reflects the relation between reactance and resistance, which measures the opposition from cellular membranes and the opposition from body fluids to the current, respectively. This indicator is closely related to health and nutrition status because it indicates both the integrity of cellular membranes and cellular water distribution. 12 PhA is inversely correlated with NUTRIC score, which reflects higher nutrition risk in individuals with lower PhA and demonstrates correlation with severity of disease (APACHE II) and direct correlation with body circumferences (mid-arm and calf circumference), measurements that reflect muscle mass indirectly. These aspects could explain the role of PhA as a prognostic marker for mortality, considering the association between nutrition risk, low muscle mass, and severity of disease in this outcome. In the ICU setting, hydration status could be assessed by BIA. 31, 32 Many studies have consistently highlighted the clinical significance of overhydration in ICU patients. 33, 34 In our sample, ECW/TBW ratio was higher in nonsurvivor critically ill patients. This indicator has demonstrated its feasibility as a diagnostic value for overhydration assessment during fluid treatment. 35 There are several limitations in this study. First, the sample size of this study was small and was conformed predominantly for males. All data were obtained from a single center, which may result in concerns regarding the generalization of the conclusions. Second, long-term survival outcomes were not accessible, because of the impact of COVID-19 on the workload of the nutrition department. Third, BIA was solely performed using InBody S10, and body water measurements might be influenced when using other devices. The authors acknowledge InBodyCo, Ltd for providing equipment for this research. InBody Co, Ltd did not interfere in the research design or results analysis. None declared. Margarita Hernández-Cardenas drafted the manuscript. All authors critically revised the manuscript, agree to be fully accountable for ensuring the integrity and accuracy of the work, and read and approved the final manuscript. Iván Armando Osuna-Padilla PhD https://orcid.org/0000-0002- Adriana Aguilar-Vargas MSc https://orcid.org/0000-0002-5153- World Health Organization Coronavirus Disease (COVID-19) Dashboard. World Health Organization COVID-19 pathophysiology: a review The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients Evaluation of nutritional risk and its association with mortality risk in severe and critically ill COVID-19 patients Nutritional risk in critically ill patients: how it is assessed, its prevalence and prognostic value: a systematic review Identifying critically-ill patients who will benefit most from nutritional therapy: further validation of the "modified NUTRIC" nutritional risk assessment tool ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection Fluid overload in the ICU: evaluation and management Evaluation of bioelectrical impedance analysis in critically ill patients: results of a Multicenter Prospective Study Update on body composition tools in clinical settings: computed tomography, ultrasound, and bioimpedance applications for assessment and monitoring Effect of intravenous infusion solutions on bioelectrical impedance spectroscopy Bioelectrical phase angle and impedance vector analysis-clinical relevance and applicability of impedance parameters Phase angle from bioelectrical impedance for the assessment of sarcopenia in cirrhosis with or without ascites Phase angle and mid arm circumference as predictors of protein energy wasting in renal replacement therapy patients Severity of human immunodeficiency virus infection is associated with decreased phase angle, fat mass and body cell mass in adults with pulmonary tuberculosis infection in Uganda Phase angle and its determinants in healthy subjects: influence of body composition American society for parenteral and enteral nutrition clinical guidelines: the validity of body composition assessment in clinical populations Association of bioelectric impedance analysis body composition and disease severity in COVID-19 hospital ward and ICU patients: the BIAC-19 study Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: a longitudinal cohort study Anthropometric Standardization Reference Manual. Human Kinetics Books Validation of predictive equations for weight and height using a metric tape Bioelectrical impedance analysis: population reference values for phase angle by age and sex Bioimpedance vector analysis for body composition in Mexican population Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer Bioelectrical impedance analysisderived phase angle at admission as a predictor of 90-day mortality in intensive care patients Assessing the accuracy of diagnostic tests Phase angle and mortality: a systematic review Phase angle is associated with length of hospital stay, readmissions, mortality, and falls in patients hospitalized in internal-medicine wards: a retrospective cohort study Bioelectrical impedance analysis values as markers to predict severity in critically ill patients Nutritional risk screening and body composition in COVID-19 patients hospitalized in an internal medicine ward The use of bio-electrical impedance analysis (BIA) to guide fluid management, resuscitation and deresuscitation in critically ill patients: a bench-to-bedside review Classification of hydration in clinical conditions: indirect and direct approaches using bioimpedance Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording Comparison of bioelectrical impedance analysis parameters for the detection of fluid overload in the prediction of mortality in patients admitted at the emergency department Assessment of body water distribution in patients with sepsis during fluid resuscitation using multifrequency direct segmental bioelectrical impedance analysis Low phase angle is associated with 60-day mortality in critically ill patients with COVID-19